Skip to main content
. 2011 Nov 8;106(2):414–423. doi: 10.1038/bjc.2011.468

Table 5a. Seminomas and non-seminoma testicular samples: (a) promoter methylation frequency in seminomas and non-seminoma testicular samples.

    Non-seminoma Seminoma
Genes Cutoff Number of tumors with methylation/total number of tumors (%, 95% CI) Number of tumors with methylation/total number of tumors (%, 95% CI)
AIM1 44.817 3/14 (21.4, 4.7–50.8) 0/43 (0, 0–8.2)
ARF 0.3 0/14 (0, 0–6.9) 5/43 (11.6, 3.9–25.1)
CCNA1 8.173 2/14 (14.3, 1.8–42.8) 2/43 (4.6, 0.6–15.8)
MCAM 1073 10/14 (71.4, 41.9–91.6) 14/43 (32.6, 19.1–48.5)
MGMT 0.193 7/14 (50, 23.0–77.0) 1/43 (2.3, 0.1–12.3)
MLH1 0.096 10/14 (71.4, 41.9–91.6) 12/43 (27.9, 15.3–43.7)
PGP9 177.09 2/14 (14.3, 1.8–42.8) 4/43 (9.3, 2.6–22.1)
S100 858.15 8/14 (57.1, 28.9–82.3) 0/43 (0, 0–8.2)
SSBP2 623.99 8/14 (57.1, 28.9–82.3) 0/43 (0, 0–8.2)
APC 19.077 7/14 (50, 23.0–77.0) 5/43 (11.6, 3.9–25.1)
RAR-β2 14.273 3/14 (21.4, 4.7–50.8) 1/43 (2.3, 0.1–12.3)
VGF 0.023 7/14 (50, 23.0–77.0) 7/43 (16.3, 6.8–30.7)
ER-α 72.072 5/14 (35.7, 12.8–64.9) 8/43 (18.6, 8.4–33.4)
ER-β 10.145 9/14 (64.3, 35.1–87.2) 12/43 (27.9, 15.3–43.7)
FKBP4 35.001 5/14 (35.7, 12.8–64.9) 1/43 (2.3, 0.1–12.3)

Abbreviation: CI=confidence interval.